Why is the CSL share price losing ground on Friday?

Why are CSL shares missing out on the market's gains on Friday?

| More on:
A sad looking scientist sitting and upset about a share price fall.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's shaping up to be a rather pleasant end to the week for ASX shares and the S&P/ASX 200 Index (ASX: XJO). So far this Friday, the ASX 200 has put on a healthy 0.82% and is back over 7,150 points. But the same can't be said for the CSL Limited (ASX: CSL) share price.

CSL shares, at the time of writing, are in the red today. They've lost 0.47% of their value so far and are currently going for $268.75 each. So what's going on here? After all, this is an underperformance of the broader market of more than 1%.

Why is the CSL share price dropping today?

Well, it's not entirely clear. There hasn't been any news or announcements out of CSL today. Or indeed for a few weeks now.

But what we do know is that the S&P/ASX 200 Health Care Index (ASX: XHJ) is one of the worst-performing sectors on the ASX 200 today so far. Amongst ASX healthcare shares, Virtus Health Ltd (ASX: VRT) is leading the losses.

Virtus shares are presently down by a notable 1.1%. This could be related to the news we heard this morning, that Virtus has terminated the transaction implementation deed with European company CapVest in favour of a rival offer from BGH Capital.

The Virtus board is now unanimously recommending shareholders go with the BGH offer, even though the termination with CapVest will see Virtus pay a $7.19 million break fee.

This could be what is dragging the Virtus share price down today, and by extension, Virtus' woes could be why the entire healthcare sector, including the CSL share price, is under the pump.

At the current CSL share price, this ASX 200 healthcare giant has a market capitalisation of $129.42 billion, with a dividend yield of 0.96%.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

This bombshell for ASX healthcare shares could hit 6 million Australians

This could have a large impact.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

2 ASX healthcare shares having a stellar run today

The ASX healthcare sector is down today but these two stocks are bucking the trend.

Read more »

A company manager presents the ASX company earnings report to shareholders at an AGM.
Healthcare Shares

Why this $13 billion ASX 200 healthcare stock is surging today

A change in sentiment for the healthcare player.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

This ASX 200 stock hit a 52-week low and a top broker thinks it can rebound

Patient investors may see this stock make a pleasing recovery.

Read more »

A couple smile as they look at a pregnancy test.
Healthcare Shares

Why this sold-off ASX healthcare share could be an exciting dividend buy

This could be a healthy stock for dividends.

Read more »

a smiling woman sits at her computer at home with a coffee alongside her, as if pleased with her investments.
Healthcare Shares

Is CSL the best ASX 100 share to buy now?

Bell Potter has good things to say about this blue chip star.

Read more »

Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23
Healthcare Shares

Down 10% in a month, are CSL shares feeling the sting of a potential disruption?

Brokers are still bullish.

Read more »

One girl leapfrogs over her friend's back.
Healthcare Shares

Doubled in a year! Does this booming ASX share have another 24% upside?

Let's take a look.

Read more »